Sartorius AG

euro adhoc: Sartorius AG
Ad-hoc-Announcement according to section 15 of the German WpHG / Sartorius AG will not take Vivascience AG public

--------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. --------------------------------------------------------------------- The Executive Board and the Supervisory Board of Sartorius AG and Vivascience AG decided not to carry out an IPO of Vivascience AG that had originally been planned for 2001 and then postponed indefinitely. The Sartorius Group’s conviction about the business model and growth opportunities of this business area remains unchanged. However, considering the current capital market environment, the Group does not see any possibility to realize profits from an IPO that would sufficiently reflect this growth potential. Rather, this business area is to be further expanded within the Sartorius Group and the available synergies are to be increasingly used. The decision taken does not have any impact on the sales revenue and earnings targets of the Sartorius Group. end of announcement euro adhoc 17.12.2004 16:06:50 --------------------------------------------------------------------- Further inquiry note: Heiko Imoehl VP Treasury & Investor Relations +49 551 308 4034 Branche: Biotechnology ISIN: DE0007165607 WKN: 716560 Index: Prime Standard, CDAX, Prime All Share, Technologie All Share Börsen: Berliner Wertpapierbörse / free trade Hamburger Wertpapierbörse / free trade Baden-Württembergische Wertpapierbörse / free trade Börse Düsseldorf / free trade Bayerische Börse / free trade Bremer Wertpapierbörse (BWB) / free trade Frankfurter Wertpapierbörse / official dealing Niedersächsische Börse zu Hannover / official dealing

Das könnte Sie auch interessieren: